Bruker Q3 GAAP diluted loss per share widens 98% to $0.81
BRKR•Bruker reported a third-quarter GAAP diluted loss of $0.81 per share, widening 98%. Non-GAAP diluted EPS rose 24% to $0.56, revenue reached $874 million, and the company reaffirmed FY26 non-GAAP EPS guidance of $2.10–$2.15.
1. Quarterly results
Bruker’s third-quarter 2026 non-GAAP diluted EPS climbed 24% year over year to $0.56, while revenue rose to $874 million. Non-GAAP operating margin expanded 4 percentage points to 16.3%, and Scientific Instruments book-to-bill exceeded one for the fifth consecutive quarter. Management expects revenue growth acceleration, continued margin expansion and double-digit EPS growth in FY27; it reaffirmed FY26 non-GAAP EPS guidance of $2.10–$2.15.
